Genomics Market Size & Trends, Sector / Industry Report & Analysis 2020, & Forecast 2021-2026 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Genomics Market


The global Genomics market size is projected to reach US$ 29.95 billion by 2026, from US$ 18.26 billion in 2020, at a CAGR of 8.6% during 2021-2026. The growth of genomic data pool due research activities has enabled physicians, biologists, and patients to further investigate the genetic predisposition to certain diseases. Clinical application of this data pool is expected to play a major role in transforming the healthcare system with respect to the provision of more accurate, effective, and reliable disease management solutions.

Although clinical application of genomic data is at a nascent stage in present, the healthcare and research community are making attempts for effective integration of genetic information into clinical workflows. Several clinical centers, such as Stanford Health Care and other cancer research centers, have begun using the available genomic information to devise personalized treatment regime. This, in turn, helps in bridging the gap between translational research and clinical diagnosis and treatment.

Lucrative growth is anticipated regarding the implementation of human genetic studies into various public health programs such consumer wellness programs, population screening, and others. The programs are mainly aimed at optimizing preventive care for common chronic diseases such as cancer and heart disease.
Growing investment by government bodies, funding agencies, and biotechnology companies to accelerate genomic research is anticipated to have major ramifications on reshaping the genomics market. International funding bodies like NIH and Welcome Trust are engaged in providing funds for genetic studies, which in turn, is expected to fuel genomic studies in both developed as well as emerging countries.

One of the most important factors anticipated to impact this market is how much and to what extent the medical community will make the use of available genomic information in personalized medicine. Scientists are combining the data generated from sequencing with diagnostics, which has proven effective in enhancing personalized treatment landscape.

Market Segmentation, Outlook & Viewpoint: Global Genomics Market

Application & Technology Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Functional Genomics

  
Real-time PCR
  
Transfection
  
SNP analysis
  
Mutational analysis
  
Microarray analysis
  
RNA interference

Pathway Analysis

  
Microarray analysis
  
Bead-based analysis
  
Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
  
Real-time PCR

Biomarker Discovery

  
DNA sequencing
  
Microarray analysis
  
Real-time PCR
  
Mass spectrometry
  
Statistical analysis
  
Bioinformatics

Epigenetics

  
Bisulfite sequencing
  
Microarray analysis
  
Chromatin immunoprecipitation (ChIP & ChIP-Seq)
  
Methylated DNA immunoprecipitation (MeDIP)
  
High resolution melt (HRM)
  
Chromatin accessibility assays

Others

Deliverables Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Products

  
Instruments/Systems/Software
  
Consumables & Reagents

Services

  
NGS-based Services
  
Core Genomics Services
  
Biomarker Translation Services
  
Computational Services
  
Others

End use Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  
Pharmaceutical and Biotechnology Companies
  
Hospitals and Clinics
  
Academic and Government Institutes
  
Clinical Research
  
Other End Users

Key Players, Recent Developments & Regional Insights: Global Genomics Market

With the decrease in sequencing costs and improvements in informatics, genetic solutions are now widely accessible in various sectors ranging from small labs to clinical settings. Key usage segments consist of pharmaceutical and biotechnology companies, hospitals and clinics, academic and government institutes, clinical research, and other end users. Among these, pharmaceutical and biotechnology companies held the largest share owing to increase in the number of genetic research studies that aimed at improving drug discovery process and development of efficacious drugs with fewer side effects.
Moreover, biotechnology companies are effectively using gene editing tools to meet the unmet needs of patients through development of recombinant and genetically engineered products. Other end users that include Direct-To-Consumers (DTC), agriculture research institutes, and forensic centers is estimated to hold the lowest share in the current market. This is primarily because of less and slow usage of genetic tools within these entities. However, in the coming years, this segment is expected to witness lucrative growth owing to fact that DTC is receiving significant attention amongst consumers, government, and genomic companies.

Deliverable Insights

Miniaturization in the instruments used in genomic applications is expected to serve as a fillip for market growth. The advantages offered by these instruments include specificity, sensitivity, and automation for the development of point-of-care diagnostics. With the maturity in development of microfabrication technology, microfluidic systems are observed to be useful for different genomic detections. The major objective of these miniaturized instruments is the development of the point-of-care device.

Moreover, rising usage of impedimetric detection is one of the promising techniques for the instruments in this market. Advancements in circuits and systems are seen to be driving the market with a technical revolution in the omics era.

Uptake of cloud based solutions which effectively and robustly manage the parallelization and distribution of input data and user code on a large number of computer nodes are attributive for estimated growth in the market. Cloud computing provides a very clear advantage of performing tasks across different parallel computing nodes and processors coupled with significant reduction in the waiting time. Introduction of cloud computing environment for processing NGS generated data has played a great role as a driving force for current genomics market.
NGS-based services have witnessed a continuous growth since its introduction. The demand for these services would remain strong with the expansion of the customer base from being limited to academic and research centers to CROs, biotech and pharma players.

Regional Insights

North America held the largest market share of overall market in 2018. Increasing investment on research by government organizations, rising patient awareness, and availability of sophisticated healthcare infrastructure has led to the increased technological advancements in this market. Local presence of key players such as Affymetrix, Inc.; Bio-Rad Laboratories, Inc.; Agilent Technologies; GE Healthcare; Illumina, Inc.; Cepheid, Inc.; and Danaher Corporation can also be attributed to the high market share.

Asia Pacific is expected to witness the fastest growth in the coming years. Developing infrastructure in these countries has led to the increased demand for biomarkers for diagnostics purposes. The market is anticipated to grow owing to increase in adoption and awareness about a number of genomics technologies in the emerging countries such as China and India for detection, treatment, and prognosis of various genetic disorders such as diabetes, cancer, and others.

There are several interesting human genome sequencing projects being carried out, one of the most recent project is Genome Asia 100K (GA 100K). Under this project, 100,000 Asians genomes will be sequenced and analyzed, which will help accelerate population-specific medical advances and precision medicine.

Genomics Market Share Insights

Major players include Thermo Fisher Scientific, Inc.; Agilent Technologies; Bio-Rad Laboratories, Inc; Danaher; BGI; F. Hoffmann-La Roche Ltd..; Illumina, Inc; Pacific Biosciences; Oxford Nanopore Technologies.; 23andMe, Inc, Foundation Medicine, Inc, and Myriad Genetics, Inc.

Companies are embracing the trend of offering varied reagents that simplify workflow process. For instance, in January 2017, BD launched Precise WTA Reagents for accurate and simple quantification of genetic information form single cell analysis. Moreover, in July 2016, SGI-DNA a company involved in synthetic genomics entered into a distribution agreement with VWR. Under this agreement, VWR provides the companies with reagents in North America and Europe.

Thus high saturation owing to a wide range of reagents and consumables has led players into adopting different strategies to sustain in the market. Agilent has also broadened its offering of CRISPR RNA libraries for genome based research.

Key Insights Covered: Global Genomics Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Genomics industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Genomics industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Genomics industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Genomics industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Genomics industry.

Research Methodology: Global Genomics Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other